OR WAIT null SECS
September 25, 2025
Article
Biolinq Shine aims to provide continuous glucose monitoring, as well as sleep and activity data, without requiring injections.
September 18, 2025
The investigational oral GLP-1 RA showed superiority in glycemic control and weight loss among patients with uncontrolled T2D.
Tirzepatide saw improvements in A1C and body mass index, which were maintained over the 30-week trial and into the 52-week extension study.
September 14, 2025
New research from Stockholm, Sweden, has shown the correlation between smoking and insulin sensitivity, with genetic susceptibility increasing the risk further.
September 07, 2025
Podcast
Explore the latest advancements in diabetes technology, including FDA-approved insulin pumps and innovative CGMs for weight management.
September 05, 2025
Hosts explore the latest findings on GLP-1 medications, semaglutide and tirzepatide, from ESC Congress 2025.
September 02, 2025
An audio recap of the top 5 stories in healthcare news from the week of 08/24-08/30.
August 28, 2025
Recent research has shown a reduction of nearly 1/3 in type 2 diabetes risk associated with adherence to a Mediterranean diet, calorie reduction, and moderate exercise.
August 26, 2025
Orforglipron met the primary and all key secondary endpoints in patients with obesity/overweight and type 2 diabetes, supporting global regulatory submissions.
August 25, 2025
The cross-sectional analysis of NHANES data highlights obesity and overweight’s influence on the development of obesity-related conditions in US youth.
